• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Singapore's COVID-19 Genomic Surveillance Programme: Strategies and Insights From a Pandemic Year

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Dec;18(12):e70060.
doi: 10.1111/irv.70060. Singapore's COVID-19 Genomic Surveillance Programme: Strategies and Insights From a Pandemic Year

Hao Yi Tan[SUP] 1 2 [/SUP], Nur Huda Khamis[SUP] 1 [/SUP], Alvin Goh[SUP] 1 [/SUP], Tania K L Mah[SUP] 1 [/SUP], Benny Yeo[SUP] 3 [/SUP], Jie Yin Ngan[SUP] 3 [/SUP], Yichen Ding[SUP] 3 [/SUP], Cui Lin[SUP] 3 [/SUP], Sae-Rom Chae[SUP] 1 [/SUP], Phoebe Lee[SUP] 1 [/SUP], Zheng Jie Marc Ho[SUP] 1 4 [/SUP]



Affiliations
Abstract

Background: During the COVID-19 pandemic, genomic surveillance was crucial for monitoring virus spread and identifying variants. Effective surveillance helped understand transmission dynamics. Singapore had success in combating COVID-19 through its surveillance programmes. This paper outlines Singapore's strategy and its impact on public health during the transition to endemicity over 54 weeks from February 2022 to February 2023.
Methods: In May 2022, Singapore expanded its acute respiratory infections (ARI) surveillance to enhance COVID-19 detection. COVID-19-positive samples from ARI cases were sent to the National Public Health Laboratory for whole genome sequencing (WGS). WGS data informed public health actions based on transmission origins and case severity.
Results: Over 54 weeks, NPHL sequenced 18,918 (73%) samples. Analysis showed 29% imported and 71% local cases. Severe cases accounted for 12% and were mostly elderly, specifically those aged 80 years old and above. Variant analysis identified 11 predominant variants and 288 subvariants. Omicron BA.2, BA.5 and XBB were initially dominant, followed by increased variant heterogeneity. Severe cases mirrored these trends.
Conclusion: Genomic surveillance was integral in Singapore's COVID-19 response, guiding timely public health decisions. Effective variant tracking supported proactive measures. The experience underscores the importance of genomic surveillance for future pandemic preparedness and emerging disease detection, emphasising its role in shaping pandemic responses and global health.

Keywords: Acute Respiratory Infections (ARI); COVID‐19; Emerging infectious diseases; Genomic Surveillance; Health Strategy; Pandemic preparedness; Singapore; Whole genome sequencing (WGS).

 
Back
Top Bottom